Literature DB >> 27709718

Body composition assessed by dual-energy X-ray absorptiometry predicts early infectious complications after liver transplantation.

C Lindqvist1, A Majeed2,3, S Wahlin2.   

Abstract

BACKGROUND: It is challenging to identify malnutrition, which is a risk factor for poor outcome in patients with liver cirrhosis. In the present study, we aimed to investigate the prevalence of malnutrition among patients listed for liver transplantation, as assessed by different methods, and also to relate dual-energy X-ray absorptiometry (DXA) to short-term post-transplant outcomes.
METHODS: In this retrospective cohort study, we reviewed the medical records of 106 patients who underwent liver transplantation in 2009-2012. Body composition was assessed by the fat-free mass index (FFMI) and fat mass index (FMI) obtained using DXA. Severe infections within 1 month, length of stay in intensive care unit and length of hospital stay were endpoints of primary interest.
RESULTS: The prevalence of malnutrition was 2-20% depending on sex and the assessment method. Thirty-nine (37%) patients developed severe infections within 1 month after liver transplantation. In multivariate analysis with logistic regression, body composition was significantly associated with post-operative infection when measured with FFMI (P = 0.043) but not with FMI (P = 0.087). Post-operative dialysis (P = 0.004) and post-operative infections (P < 0.001) were significantly associated with length of stay in hospital. Post-operative bleeding (P = 0.015), duration of mechanical ventilation (P < 0.001) and the need for dialysis (P < 0.001), but not body composition, were significant predictors of the length of stay in the intensive care unit.
CONCLUSIONS: The prevalence of malnutrition depends on assessment method. FFMI is an independent predictor for early post-transplant infections. Body composition measured by DXA during the pretransplant evaluation provides valuable information about nutritional status in patients with liver cirrhosis.
© 2016 The British Dietetic Association Ltd.

Entities:  

Keywords:  body composition; dual-energy X-ray absorptiometry; fat free mass index; liver transplantation; outcome

Mesh:

Year:  2016        PMID: 27709718     DOI: 10.1111/jhn.12417

Source DB:  PubMed          Journal:  J Hum Nutr Diet        ISSN: 0952-3871            Impact factor:   3.089


  6 in total

1.  Longitudinal assessment of T cell inhibitory receptors in liver transplant recipients and their association with posttransplant infections.

Authors:  Krupa R Mysore; Rafik M Ghobrial; Sunil Kannanganat; Laurie J Minze; Edward A Graviss; Duc T Nguyen; Katherine K Perez; Xian C Li
Journal:  Am J Transplant       Date:  2017-11-20       Impact factor: 8.086

Review 2.  Implications of low muscle mass across the continuum of care: a narrative review.

Authors:  Carla M Prado; Sarah A Purcell; Carolyn Alish; Suzette L Pereira; Nicolaas E Deutz; Daren K Heyland; Bret H Goodpaster; Kelly A Tappenden; Steven B Heymsfield
Journal:  Ann Med       Date:  2018-09-12       Impact factor: 4.709

Review 3.  Malnutrition in Patients with Liver Cirrhosis.

Authors:  Julia Traub; Lisa Reiss; Benard Aliwa; Vanessa Stadlbauer
Journal:  Nutrients       Date:  2021-02-07       Impact factor: 5.717

4.  Relation of Malnutrition and Nosocomical Infections in Cancer Patients in Hospital: An Observational Study.

Authors:  Bianca Tabita Muresan; Martín Núñez-Abad; Ana Artero; Jaime Rios Rios; Alberto Jacobo Cunquero-Tomás; Vega Iranzo; Javier Garrido; Ana Jiménez-Portilla; Carlos Camps Herrero; Carlos J Sánchez Juan
Journal:  J Nutr Metab       Date:  2022-08-16

Review 5.  Nutritional assessment in patients with liver cirrhosis.

Authors:  Sara Haj Ali; Awni Abu Sneineh; Reem Hasweh
Journal:  World J Hepatol       Date:  2022-09-27

Review 6.  A Comprehensive Review of Bioelectrical Impedance Analysis and Other Methods in the Assessment of Nutritional Status in Patients with Liver Cirrhosis.

Authors:  Halina Cichoż-Lach; Agata Michalak
Journal:  Gastroenterol Res Pract       Date:  2017-08-13       Impact factor: 2.260

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.